| __timestamp | Dynavax Technologies Corporation | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 26684000 |
| Thursday, January 1, 2015 | 22180000 | 29829000 |
| Friday, January 1, 2016 | 37257000 | 39578000 |
| Sunday, January 1, 2017 | 27367000 | 43277000 |
| Monday, January 1, 2018 | 64770000 | 48645000 |
| Tuesday, January 1, 2019 | 74986000 | 52934000 |
| Wednesday, January 1, 2020 | 79256000 | 61349000 |
| Friday, January 1, 2021 | 100156000 | 127125000 |
| Saturday, January 1, 2022 | 131408000 | 136106000 |
| Sunday, January 1, 2023 | 152946000 | 133175999 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: HUTCHMED (China) Limited and Dynavax Technologies Corporation, from 2014 to 2023. Over this period, Dynavax's SG&A expenses surged by approximately 760%, reflecting a strategic expansion and increased operational activities. In contrast, HUTCHMED's expenses grew by around 400%, indicating a more measured approach.
This trend highlights Dynavax's aggressive market strategies, while HUTCHMED's growth suggests a focus on sustainable expansion.
Eli Lilly and Company or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Sanofi and Dynavax Technologies Corporation
argenx SE and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Dynavax Technologies Corporation Trends and Insights
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Axsome Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
CymaBay Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Amicus Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: HUTCHMED (China) Limited vs Novavax, Inc.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation